Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs

Japanese Journal of Pharmacology

Volumn 76, Issue 1, 1998, Pages 31-37

  Imamura, Hiroshi ^a   Furukawa, Yasuyuki ^a   Kasama, Miho ^a   Hoyano, Yuji ^a   Yonezawa, Takanori ^a   Chiba, Shigetoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Disopyramide; Dofetilide; E 4031; Parasympathetic nervous system; Refractory period

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; DISOPYRAMIDE; DOFETILIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOG; DOSE RESPONSE; ELECTROCARDIOGRAM; FEMALE; HEART FUNCTION; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART RIGHT ATRIUM; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POTASSIUM CURRENT; SINUS RHYTHM; VAGUS NERVE STIMULATION;

EID: 0031915716     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.31     Document Type: Article

References (30)

1. Colatsky TJ, Follmer CH and Starmer CF: Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82, 2235-2242 (1990)
2. Gwilt M, Arrowsmith JE, Blackburn KJ, Burges RA, Cross PE, Dalrymple HW and Higgins AJ: UK-68,798: A novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells. J Pharmacol Exp Ther 256, 318-324 (1991)
3. Gwilt M, Blackburn KJ, Burges RA, Higgins AJ, Milne AA and Solca AM: Electropharmacology of dofetilide, a new class III agent, in anesthetized dogs. Eur J Pharmacol 215, 137-144 (1992)
4. Sawada K, Nomoto K and Hiraoka M: Effects of a novel class 3 antiarrhythmic agent, E-4031, on ventricular arrhythmias. Jpn Circ J 52, 919 (1988)
5. Wettwer E, Scholtysik G, Schaad A, Himmel H and Ravens U: Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 17, 480-487 (1991)
6. + current: Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96, 195-215 (1990)
7. + current is composed of two currents in guinea pig atrial cells. Am J Physiol 260, H393-H399 (1991)
8. + current by dofetilide. Circ Res 72, 75-83 (1993)
9. Levy MN and Schwartz PJ: Vagal Control of the Heart: Experimental Basis and Clinical Implications, Futura Publishing Co, Inc, Armons (1994)
10. Imamura H, Furukawa Y, Nakano H, Kasama M, Hoyano Y and Chiba S: Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs. J Pharmacol Exp Ther 276, 467-472 (1996)
11. Alessi R, Nusynowitz M, Abildskov JA and Moe GK: Nonuniform distribution of vagal effects on the atrial refractory period. Am J Physiol 194, 406-410 (1958)
12. De Ferrari GM, Vanoli E and Schwartz PJ: Cardiac vagal activity, myocardial ischemia and sudden death. In Cardiac Electrophysiology: From Cell to Bedside, Edited by Zipes DP and Jalife J, pp 422-434, WB Saunders Co, Philadelphia (1995)
13. Mokler CM and Van Arman CG: Pharmacology of a new anti-arrhythmic agent, γ-diisopropylamino-α-phenyl-α-(2-pyridyl)-butyramide (SC-7031). J Pharmacol Exp Ther 136, 114-124 (1962)
14. Birkhead JS and Vaughan Williams EM: Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J 39, 657-660 (1977)
15. Mirro MJ, Manalan AS, Bailey JC and Watanabe AM: Anti-cholinergic effects of disopyramide and quinidine on guinea pig myocardium: Mediation by direct muscarinic receptor blockade. Circ Res 47, 855-865 (1980)
16. Levy MN, Ng ML and Zieske H: Functional distribution of the peripheral cardiac sympathetic pathways. Circ Res 19, 650-661 (1966)
17. K blocking drug, UK-68,798: Potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 16, 401-410 (1990)
18. Yang T, Tande PM and Refsum H: Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of β-blocking action on isolated guinea pig atria. Br J Pharmacol 103, 1417-1420 (1991)
19. Wallace AA, Stupienski RF, Brookes LM, Selnick HG, Claremon DA and Lynch JJ Jr: Cardiac electrophysiologic and inotropic actions of new and potent methanesulfonanilide class III antiarrhythmic agents in anesthetized dogs. J Cardiovasc Pharmacol 18, 687-695 (1991)
20. Spinelli W, Parsons RW and Colatsky TJ: Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68,798, E-4031, and dl-sotalol. J Cardiovasc Pharmacol 20, 913-922 (1992)
21. Verheijck EE, Ginneken ACG, Bourier J and Bouman LN: Effects of delayed rectifier current blockade by E-4031 on impulse generation in single sinoatrial nodal myocytes of the rabbit. Circ Res 76, 607-615 (1995)
22. Mirro MJ, Watanabe AM and Bailey JC: Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac Purkinje fibers: Dependence on underlying cholinergic tone. Circ Res 46, 660-668 (1980)
23. Nakajima T, Kurachi Y, Ito H, Takikawa R and Sugimoto T: Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: Mediation by different molecular mechanisms. Circ Res 64, 297-303 (1989)
24. Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS and Dalrymple HW: Dofetilide, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol 20, S96-S105 (1992)
25. Mori K, Hara Y, Saito T, Masuda Y and Nakaya H: Anti-cholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells: different molecular mechanisms. Circulation 91, 2834-2843 (1995)
26. + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262, 809-817 (1992)
27. Krafte DS and Volberg WA: Voltage dependence of cardiac delayed rectifier block by methanesulfonamide class III antiarrhythmic agents. J Cardiovasc Pharmacol 23, 37-41 (1994)
28. Nattel S, Euler DE, Spear JF and Moore EN: Autonomic control of ventricular refractoriness. Am J Physiol 241, H878-H882 (1981)
29. Prytowsky EN, Jackman WM, Rinkenberger RL, Heger JJ and Zipes DP: Effect of autonomic blockade on ventricular refractoriness and atrioventricular conduction in man: evidence supporting a direct cholinergic action on ventricular muscle refractoriness. Circ Res 49, 511-518 (1981)
30. Hondeghem LM and Snyders DJ: Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 81, 686-690 (1990)